Biofrontera AG

Overview

• IndustryPharmaceutical Preparations¹
• Headquarters2M¹

See how the biggest companies compare on our leaderboards

Corporate structure

Biofrontera AG sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Filings

38 filings to the SEC since October 2021: 3 large holders, 35 other. The latest 20:

1. Mar 11, 2022EFFECT EDGAR
2. Mar 10, 20226-K EDGAR
3. Mar 9, 202215F-12B EDGAR
4. Mar 9, 2022POS AM EDGAR
5. Mar 9, 2022S-8 POS EDGAR
6. Feb 25, 2022SC 13D/A AMENDMENT NO. 16 TO SCHEDULE 13D EDGAR
7. Feb 24, 202225 EDGAR
8. Feb 24, 20226-K EDGAR
9. Feb 22, 20226-K EDGAR
10. Feb 14, 20226-K EDGAR
11. Feb 1, 20226-K EDGAR
12. Jan 13, 20226-K EDGAR
13. Dec 29, 20216-K EDGAR
14. Dec 21, 2021SC 13D/A AMENDMENT NO. 15 TO SCHEDULE 13D EDGAR
15. Dec 14, 20216-K EDGAR
16. Dec 13, 20216-K EDGAR
17. Dec 8, 20216-K EDGAR
18. Dec 2, 20216-K EDGAR
19. Dec 2, 20216-K EDGAR
20. Dec 2, 20216-K EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Balaton Aktiengesellschaft DeutscheSC 13D/A, 3 filings Nov 29, 2021 to Feb 25, 2022²

Stakes it holds

Biofrontera AG has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Biofrontera Inc.SC 13G Feb 10, 2022³